Veterinary Oncology Market Report 2026

Veterinary Oncology Market Overview

• Veterinary Oncology market size has reached to $0.45 billion in 2025 • Expected to grow to $0.77 billion in 2030 at a compound annual growth rate (CAGR) of 11.3% • Growth Driver: Rising Pet Cancer Rates Propel Growth In The Veterinary Oncology Market • Market Trend: Innovative Approaches to Cancer Vaccines • Asia-Pacific was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under Veterinary Oncology Market?

Veterinary oncology refers to the diagnosis and treatment of cancer by specially trained experts to integrate cancer treatment with underlying conditions while sustaining a quality of life in animals. It deals with cancer medicine and treatment services in animals. The main types of therapy in veterinary oncology are surgery, radiology, chemotherapy, and others. Surgery refers to the technique to remove or repair a body part or to determine the presence of disease. The various animal types involved are equine, canine, feline, and others, that involve cancer types such as lymphomas, mast cell cancer, mammary and squamous cell cancer, and others.

What Is The Veterinary Oncology Market Growth Forecast?

The veterinary oncology market size is expected to see rapid growth in the next few years. It will grow to $0.77 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing demand for personalized and targeted therapies, growth in advanced radiology and imaging adoption, rising use of immunotherapy and supportive care, development of minimally invasive surgical techniques, integration of combination chemotherapy and targeted therapy protocols. Major trends in the forecast period include expansion of targeted and personalized veterinary cancer therapies, growth in minimally invasive surgical techniques, increasing adoption of advanced radiology and imaging technologies, development of combination chemotherapy protocols, integration of immunotherapy and supportive care in treatment plans.

Global Veterinary Oncology Market Segmentation

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies 2) By Animal Type: Equine, Canine, Feline, Other Animal Types 3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types Subsegments: 1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation 2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques 3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents 4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

What Is The Driver Of The Veterinary Oncology Market?

The growing prevalence of cancer in pets is expected to propel the veterinary oncology market going forward. Cancer is a disorder in which a few of the body's cells grow out of control and spread to other body sections. Cancer in pets refers to the physical manifestations of a tumor, such as swelling. Veterinary oncology is focused on cancer diagnosis and therapy in animals by reducing metastasis and disease spread. As a result, an increase in pet cancer will boost the need for veterinary oncology. For instance, according to the The Cancer Letter, a US-based publication that covers cancer research stated that in 2024, an estimated 6 million pet dogs will be diagnosed with cancer in the United States. Furthermore, according to the British Small Animal Veterinary Association (BSAVA), a UK-based veterinary community, November 2023, it’s estimated that 1 in 4 dogs and 1 in 5 cats will be diagnosed with cancer in their lifetime. Therefore, the growing prevalence of cancer in pets is driving the veterinary oncology industry.

Key Players In The Global Veterinary Oncology Market

Major companies operating in the veterinary oncology market are PetCure Oncology Inc., Zoetis Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, AB Science SAS, Pfizer Inc., Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, ZENOAQ GmbH, Oncovet Clinical Research Inc.

Global Veterinary Oncology Market Trends and Insights

Major companies operating in the veterinary oncology market are focused on developing neoantigens, which are unique tumor-specific antigens that arise from mutations in cancer cells. Neoantigens are unique protein fragments that arise from tumor-specific mutations in cancer cells. Unlike normal antigens found in healthy tissues, neoantigens are produced as a result of genetic changes (mutations) within the tumor's DNA. For instance, in October 2024, Biotechnology company, a US-based company launched cancer vaccine trial for dogs. Neoantigens are being explored in the development of cancer vaccines and other immunotherapies, with the goal of enhancing the immune response specifically against cancer cells while sparing normal cells.

What Are Latest Mergers And Acquisitions In The Veterinary Oncology Market?

In September 2024, Boehringer Ingelheim, a Germany‑based pharmaceutical company, acquired Saiba Animal Health AG for an undisclosed amount. With this acquisition, Boehringer Ingelheim aimed to bolster its veterinary therapeutics pipeline, adding Saiba’s innovative technology platform for developing novel therapeutic medicines that may support chronic disease management, including cancer‑related treatments for pets. Saiba Animal Health AG is a Switzerland‑based developer of therapeutic vaccines and innovative technology platforms targeting chronic diseases in companion animals, with potential applicability across oncology and related therapeutic areas.

Regional Outlook

Asia-Pacific was the largest region in the veterinary oncology market in 2025. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Veterinary Oncology Market?

The veterinary oncology market includes revenues earned by entities by providing cryosurgery, comprehensive care, immunotherapy, and palliative care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.